Successful Treatment with Olanzapine of Psychosis in Dentatorubral-pallidoluysian Atrophy: A Case Report
Clinical Psychopharmacology and Neuroscience
;
: 221-223, 2018.
Article
in English
| WPRIM
| ID: wpr-714646
ABSTRACT
Patients with dentatorubral-pallidoluysian atrophy occasionally elicit psychosis. So far, one study reported first generation antipsychotics drugs may provide an effective treatment; however, there is no literature on the benefits of second generation antipsychotics. We report on a 44-year-old man with dentatorubral-pallidoluysian atrophy whose psychotic symptoms were effectively treated with olanzapine. Our observation suggests some second generation antipsychotics provide a therapeutic option for ameliorating psychosis in dentatorubral-pallidoluysian atrophy.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Psychotic Disorders
/
Antipsychotic Agents
/
Spinocerebellar Degenerations
/
Myoclonic Epilepsies, Progressive
Limits:
Adult
/
Humans
Language:
English
Journal:
Clinical Psychopharmacology and Neuroscience
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS